Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the rate of engraftment with combined haploidentical-cord
blood transplantation. The secondary objective is to evaluate the incidence and severity of
acute and chronic graft-versus-host disease (GVHD).